Mallinckrodt's terlipressin key phase 3 test CONFIRM reaches major and secondary endpoints
-
Last Update: 2020-06-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently,(http:// of the http://company of Mallinckrodt Bio
Medicine sinannounced that its terlipressin had reached the main and all secondary end points of the trial in the key phase 3trial(http:///confirm
/i for the treatment of type 1 liver and kidney syndrome (HRS-1)Mallinckrodt is expected to submitnew drug(http://application (NDA) for triebalin early next yearAbout terlipressinterlipressin is a precursordrug(http:// of the precursor of vascular pressure pressure, mainly acting on the visceral circulatory arterial smooth muscle V1 receptor, selectively constricting visceral blood vessels, reducing blood flow and pressure in the venous veins Terlipressin has the effect of improving kidney function and promoting the excretion of sodium in the urine in patients with ascites Up to 300 patients participated in the /confirm
/i trial, a multicenter trial in the United States and Canada designed to verify the effectiveness and safety of triepressurein treatment HRS-1 The selected patients included patients with cirrhosis and ascites with acute renal failure, who did not respond to diuretics or albumin The trial reached the main endpoint of reversing HRS symptoms, including improving kidney function, avoiding dialysis, and improving short-term survival in patients
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
